Unknown

Dataset Information

0

SARS-CoV-2 Variants and Vaccines.

ABSTRACT: Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.

SUBMITTER: Krause PR 

PROVIDER: S-EPMC8262623 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines.
| S-EPMC8713083 | biostudies-literature
Unknown COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.
| S-EPMC8301790 | biostudies-literature
Unknown Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle
| EMPIAR-10999 | biostudies-other
Unknown Tilt series of SARS-CoV-2 virions, Wuhan/Alpha/Beta/Delta variants
| EMPIAR-11070 | biostudies-other
Unknown Missense variants in human ACE2 modify binding to SARS-CoV-2 Spike
| S-BSST649 | biostudies-other
Unknown SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system.
| S-EPMC8577721 | biostudies-literature
Unknown SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.
| S-EPMC8121504 | biostudies-literature
Transcriptomics Responses to SARS-CoV-2 variants in hACE2 transgenic mice
2023-09-22 | E-MTAB-13308 | biostudies-arrayexpress
Unknown Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance
| S-SCDT-EMBOR-2021-54199V1 | biostudies-other
Unknown Structures from "Engineering Neutralizing SARS-CoV Antibodies to Bind SARS-CoV-2"
| S-BSST379 | biostudies-other